Heron Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Heron Therapeutics (HRTX) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Heron Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Heron Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Heron Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $5.0M | 1.4M | 3.50 |
| 2024-03-31 | $3.9M | 1.4M | 2.77 |
| 2023-12-31 | $1.7M | 985k | 1.70 |
| 2023-09-30 | $624k | 606k | 1.03 |
| 2023-06-30 | $657k | 566k | 1.16 |
| 2023-03-31 | $611k | 404k | 1.51 |
| 2022-12-31 | $2.9M | 1.2M | 2.50 |
| 2022-06-30 | $3.6M | 1.3M | 2.79 |
| 2022-03-31 | $13M | 2.3M | 5.72 |
| 2021-12-31 | $18M | 1.9M | 9.13 |
| 2021-09-30 | $17M | 1.6M | 10.69 |
| 2021-03-31 | $20M | 1.2M | 16.21 |
| 2020-12-31 | $24M | 1.1M | 21.17 |
| 2020-09-30 | $15M | 1.0M | 14.82 |
| 2020-06-30 | $18M | 1.2M | 14.71 |
| 2019-12-31 | $36M | 1.5M | 23.50 |
| 2019-09-30 | $13M | 690k | 18.50 |
| 2019-06-30 | $17M | 907k | 18.59 |
| 2019-03-31 | $19M | 791k | 24.44 |
| 2018-12-31 | $18M | 696k | 25.93 |
| 2018-09-30 | $17M | 543k | 31.65 |
| 2018-06-30 | $19M | 480k | 38.85 |
| 2018-03-31 | $8.6M | 312k | 27.60 |
| 2017-12-31 | $3.4M | 186k | 18.10 |
| 2017-09-30 | $5.1M | 314k | 16.15 |
| 2017-06-30 | $5.8M | 420k | 13.85 |
| 2017-03-31 | $3.4M | 228k | 15.00 |
| 2016-12-31 | $370k | 28k | 13.08 |
| 2016-09-30 | $749k | 43k | 17.24 |
| 2016-06-30 | $317k | 18k | 18.07 |
| 2016-03-31 | $5.0M | 262k | 18.99 |
| 2015-12-31 | $1.7M | 63k | 26.71 |
| 2015-09-30 | $55M | 2.2M | 24.40 |
| 2015-06-30 | $476k | 15k | 31.17 |
| 2014-03-31 | $234k | 17k | 13.93 |